St. Jude Medical

St. Jude Medical, founded in 1976 by Manuel A. Villafana, was a prominent global medical device company based in St. Paul, Minnesota. The company specialized in cardiovascular products, particularly mechanical heart valves, pacemakers, and implantable cardioverter defibrillators (ICDs). Its flagship product, the bileaflet mechanical heart valve, featured a pyrolytic carbon coating that minimized blood clotting risks. St. Jude Medical went public in 1977 and became a Fortune 500 company by 2010, later being acquired by Abbott Laboratories in January 2017. With operations in Massachusetts, Canada, Puerto Rico, and Belgium, St. Jude Medical's products were utilized in around 1,500 medical centers across 75 countries. The company expanded its offerings through strategic acquisitions, enhancing its portfolio to include specialized cardiovascular catheters and vascular closure devices. St. Jude Medical was dedicated to supporting healthcare providers with innovative medical devices and clinical support for cardiovascular applications, establishing a strong reputation in the industry.

• Employees 6200
• Founded 1976
• Annual Revenue $5541000000
• Total Funding $135120000